Marshall Wace North America’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Marshall Wace North America’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,220	Closed	-$379K	–	1863
2021 Q2	$379K	Buy	+11,220	New	+$286K	﹤0.01%	1237

Marshall Wace North America's CNST Position: Q3 2021 in Review

Marshall Wace North America sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 11,220 shares — an estimated $379K sold.

Marshall Wace North America first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $379K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Marshall Wace North America reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 11,220 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $379K.
Marshall Wace North America first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Marshall Wace North America's Constellation Pharmaceuticals, Inc. position peaked at $379K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.